Effectiveness of a Self-management Program After Traumatic Injury
Launched by OSLO UNIVERSITY HOSPITAL · Mar 5, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a self-management program designed to help individuals recover from moderate to severe traumatic injuries, such as those caused by accidents. The program aims to improve patients' ability to manage their recovery by teaching them skills and strategies to cope with the challenges they face after their injury. It consists of eight group sessions where participants will learn about their injuries, develop new skills, and share their experiences with others in similar situations. This study focuses on people who are between 18 and 72 years old, have been admitted to Oslo University Hospital within 72 hours of their injury, and have stayed in the hospital for at least two days.
Participants in the study will be randomly assigned to either the self-management program or a control group that receives standard treatment. Some patients will also have the option to choose which group they prefer, which will help researchers understand how personal preferences affect recovery outcomes. It's important to note that individuals with certain conditions, such as severe cognitive impairment or substance dependence, will not be eligible to participate. Overall, this trial aims to find out if this self-management support program can help improve the quality of life and daily functioning for those recovering from traumatic injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults residing in the southeast region of Norway who are aged between 18 and 72 years.
- • Admitted to OUH directly or after transfer from local hospitals within 72 hours of injury.
- • At least a two-day hospital stay.
- • Traumatic injury corresponding to a New Injury Severity Scale score (NISS) \>9.
- • Patients reporting injury-related symptoms, functional impairments, and/or difficulties with daily activities at the discharge from OUH.
- Exclusion Criteria:
- • Cognitive function corresponding to a Mini Mental Status score (MMS) \< 20 points.
- • Psychiatric diseases that require treatment.
- • Drug/alcohol dependence that require treatment.
- • Complete spinal cord injury and isolated thoracic or abdominal injury
- • Insufficient command of Norwegian
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Nada Andelic
Study Chair
Oslo University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported